Pineal region teratoma

Summary

Pineal region teratoma (MONDO:0004015) is a disease. A subtype of central nervous system teratoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	pineal region teratoma
Mondo ID	MONDO:0004015
DOID	DOID:6856
NCIT	C6753
UMLS	C1335419
MedGen	277517
GARD	0023777
Anatomy (UBERON)	UBERON:0001905
Is cancer (heuristic)	no

Also known as: pineal area teratoma · teratoma of pineal area · teratoma of pineal region · teratoma of the pineal area · teratoma of the pineal region

Disease family

This is a subtype of central nervous system teratoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › germ cell tumor › nongerminomatous germ cell tumor › teratoma › central nervous system teratoma › pineal region teratoma

Related subtypes (5): spinal cord intramedullary teratoma, adult central nervous system teratoma, central nervous system mature teratoma, central nervous system immature teratoma, spinal cord dermoid cyst

Subtypes (3): pineal region mature teratoma, pineal region immature teratoma, teratoma, pineal

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.